Category Archives: Cancer Treatment

Dr. David Samadi Explains How Processed Foods Are Cancer-Friendly

Researcher says a link with bad eating habits has been found in about 30 percent of cancer cases. In fact, in a recent report, Dr. David Samadi, Chairman of Urology at Lenox Hill Hospital pointed out “Why food can be your best cancer-fighting friend.”

This data, compiled by the World Fund for Cancer Research is quite relevant, especially considering that a third of the cancer cases could come down to the foods we consume. Dr. Samadi continuously spotlights how food impacts diseases. Doctors worldwide agree that reducing the number of calories, reducing the consumption of meat and increasing that of fruit and vegetables diminishes the risk of cancer.

We Are What We Eat

Ultra-processed or highly processed foods, which in some developed countries, like the United States, account for more than 50% of a person’s food source. These are often referred to as “industrial foods,” and are rich in sugars, fats, salt, refined flours, high fructose corn syrup, and while not necessarily always very high in calories, these processed foods contain lots of additives, preservatives, and dyes. “Convenience is the reason why we consume processed foods,” and “the culture of food has changed,” says Dr. David Samadi. With the processing of foods today, is it really surprising there is a relationship between diets and the development of some cancers?

Consider treated or processed meats, such as sausages or hot dogs. These are treated with preservatives to improve their shelf life or taste. Nitrite and nitrate, which are used for the production of sausages and hot dogs, are especially dangerous.

And the excessive and regular consumption of refined flour is associated with the increase in cases of breast cancer. This food also has a high glycemic index which increases blood sugar levels, promoting the development of cancer cells.

Maintaining a healthy diet and normal weight is one of the keys to diminishing the risks of cancer says Dr. Samadi. It is advisable to base your diet on plant-based and unrefined foods. Many foods have a protective action against cancer like broccoli, cabbage, green beans, pumpkin, green leafy vegetables, potatoes, and legumes.

Dr. Samadi is internationally acclaimed for his contributions to the urologic medical field. Besides being a visiting doctor at numerous institutions overseas, he successfully modified prostate surgery, inventing the SMART technique. This resulted in quicker recovery time for patients, and a higher success rate. At present, Dr. Samadi is the Chief of Robotic Surgery and Chairman of Urology at Lenox Hill Hospital.

He’s authored close to 60 peer-reviewed published medical papers, mentors and trains colleagues and medical students, and continues to help navigate patients through diagnosis, treatment, and after-care options for prostate cancer and other urologic diseases.

Contact Dr. David Samadi:

The Accomplished Eric Lefkofsky

Eric Lefkofksky Career History & Background

In a field as competitive and as demanding as the business field is, it is very uncommon to find individuals like Eric Lefkofsky. While there are numerous successful entrepreneurs in the business scene, perhaps very few have done so with the amount of commitment and dedication as has Eric Lefkofsky. In fact, that is one of the many reasons for why he is as beloved and respected for what he does today. In addition, it has been a big factor for why Eric Lefkofsky is seen as one of the most highly-regarded professionals in all of the business. Not to mention the number of business connections and relationships he has built over the years, and it becomes more clear to understand how Eric Lefkofksky has accomplished so much in a relatively short time period. Worth mentioning, there are not enough descriptions of Eric Lefkofsky’s career that would not be an understatement. As amazing as that sounds, this just goes to show how truly accomplished Eric Lefkofsky is being a prominent entrepreneur. Having said all of that, there are numerous examples of Eric that show how effective he has been at what he does. So, as a way of gettings better understanding of the ways Eric Lefkofsky has accomplished so much in his career, let us recap an article on Eric and his quest for answers.

Eric Lefkofsky& His Quest For Answers

As alluded to before, there are many ways Eric has reached the level of status he has today. If we were to sit here and list them all, we will be here a very long time. However, an article by on Eric does a great job at summarizing his skills. In the article, it goes on to explain how his valued efforts have gotten him where he is today. Furthermore, it goes on to explain how relatively easy it was for him to achieve what he has today. Simply put, his undying quest for answers and a better understanding of thinf=gs is what kept him successful. All in all, it is easy to see how Eric Lefkofsky is and will continue to be a successful figurehead in the business world.

Contact Eric Lefkofsky:

Eric Lefkofsky Participates in Fight for Cancer

As the year’s pass, cost of health care has been increasing. Patients intense demands, and costly attention have contributed to the higher medical care. As reported in JAMA, growth in population and getting aged can as well result in the spending cost. According to Joseph Dieleman, the study leader, medical costs for different diseases depend on various factors.

For instance, during the period of study, diabetes recorded the most significant increase of $ 64 billion annually with $40 billion spend on medication. Each factor analyzed has an impact on the increased medical care charges. Dieleman, mentioned aging, pharmaceuticals usage, diabetes prevalence and population growth as some of the cost factors in the US healthcare upsurge.

Neck pain and low back recorded an increase of 8.5% for the inpatient care, with an annual spending of $57 billion. Regardless of reduction in medical expenditure summing up to $201 billion, the inpatient cost for all illnesses increased by $439 billion from $258 billion per annum. The efforts to reduce medical spending has not fully impacted as projected.

According to the director of Centre for Health Policy Peter Bach, pharmaceuticals are not a significant reduction of cost. The costly drugs, prescribed to patients to prevent hospitalization, is not a crucial factor in medical care spending. Cost breakdown would aid researchers in analyzing the specific spending factors.

Eric Lefkofsky

Born on 1969 September 2nd and an American businessman, Eric Lefkofsky is a co-founder of Tempus. He chairs the technology company known to be at the forefront in fighting cancer. The entrepreneur traded carpets at the University of Michigan. In collaboration with his colleague Brad Keywell, they co-founded Brandon Apparel after the completion of law school. They later founded Echo Global Logistics, in 2005 a freight and logistics business. Eric invented Starbelly, a technology company that aimed at products advertisement.

Eric Lefkofsky is an investor who has participated in the formation of Mediaocean, Inner Workings, Uptake technologies, and LightBank. He launched a family Foundation in 2016, that is aimed at supporting educational, scientific and charitable institutions. The focus of this foundation is on children and has offered support to over 50 organizations. The charity center is under the management of Lefkofsky family.

Eric Lefkofsky Enters the Battle Against Cancer

Advanced technology involving data is allowing one company to take a different route in the fight against cancer. Tempus, which is a company formed by Eric Lefkofsky to battle the disease, intends to give University of Chicago doctors data to help them treat breast cancer patients better. A recent partnership between Tempus and the University of Chicago Medicine was made to advance treatment options in this category even more.

Personalized Treatment Plans

The new merger will allow Tempus to complete a multilevel process involving molecular sequencing and analysis. Once the company finishes its evaluations, it forwards the data to breast cancer specialists who work for the University of Chicago Medicine. These specialists will use this information to develop personalized treatment plans for their patients. According to Tempus, researchers will assess the data from about 1,000 breast cancer patients to start. The company’s goal is to help researchers and doctors spot patterns that will help them determine how a patient will respond to a particular treatment. Tempus believes that this will allow cancer specialists to create better treatment plans, improving patient outcomes for learn more: click here.

Dr. OlufunmilayoOlopade, the University of Chicago’s professor of human genetics and medicine and its global health dean, said, “Although breast cancer is among the most common cancers, there is relatively little accessible data on the millions of patients who have battled the disease.” He went on to say, “This forces too many physicians to make treatment decisions without the benefit of highly specific genetic information that could help them make better informed and precisely targeted decisions.”

Tempus wants to establish the world’s largest clinically annotated molecular information collection for breast cancer treatment. Because the company uses genomic sequencing combined with machine learning, Tempus is able to help doctors develop personalized treatment decisions for patients in real-time.

The partnership with the University of Chicago is the latest collaboration that Tempus has entered into. In its battle against cancer, the company is also working medical facilities like the Mayo Clinic, the Rush University Medical Center, the University of Michigan, Penn Medicine and the Robert H. Lurie Comprehensive Center of Northwestern University.

A Missing Element

To treat breast cancer successfully, medical professionals require data about different things and conditions. According to Lefkofsky, this information is missing from today’s medical research. While there’s plenty of patient data available, the lack of sources that combine therapeutic data with genomic information is lacking.

Lefkofsky said, “Gathering molecular data is one thing, but you also need clinical data. You need therapeutic and outcome response data.” This means that in addition to a patient’s RNA and DNA makeup, medical researchers should be tracking what treatments patients are on and whether or not they’re responding. If a medical researcher is assessing a group of patients who are on a particular drug, then they should be looking into why it is effective for some patients and not others. To do this, they’ll need to consider what may be happening with the patients who are not responding to the treatment. For instance, do they have another medical condition? Or, are they taking an additional drug?

Lefkofsky said, “If you were to go into any of the cancer centers and ask who took Herceptin over two years and how they did, they’d need a grant and at least 90 days. That’s the sort of data that should flow freely between researchers, clinicians and others.”

A Personal Connection

Eric started Tempus after doctors determined that his wife had breast cancer. While learning how to treat her disease, he said that it occurred to him that truck drivers have better information about the best way to perform their jobs than oncologists do. Too often, medical professionals don’t have the information about how well a particular treatment works in other patients.

With Tempus, researchers are creating a technology layer over electronic medical records and the pathology systems, allowing them to accumulate data, scrub it and send a clean report back to the medical professionals. This method makes it quicker and easier for these experts to validate and confirm the data’s results. After completing this step, researchers can combine it into a data pool to detect patterns between the treatments that are being used and the results.

Lefkofsky said, “My goal is to get most people starting in oncology and then those working on neurological disorders to use our platform to collect data for analysis.” He compared it to personalizing vaccines as this is another treatment area that industry experts are trying to improve.

About Tempus

Eric Lefkofsky founded Tempus in 2015. The company’s headquarters are at 600 W. Chicago, which is the same location as Lefkofsky’s other major companies including Groupon, Drivin and Lightbank.

Every year, about a quarter of a million people receive the news that they have breast cancer in the U.S. Treatment centers are looking into new ways to treat the disease. To this end, The Cancer Genome Atlas, or TCGA, which is in partnership with Tempus, has compiled data for slightly more than 1,000 breast cancer patients. TCGA has sequenced and annotated patient information like critical clinical information, treatments used and outcomes. According to researchers, breast cancer genetics are complex. This complexity makes it tough to spot treatment patterns that are therapeutically relevant.

Eric Lefkofsky: Co-Founder and CEO

As the cofounder of Groupon, Lightbank and Uptake Technologies, Erik Lefkofsky is no stranger to starting new companies. Along with being comfortable founding them, Lefkofsky is also successful at establishing companies that are technology-based. He started Echo Global Logistics, which is a firm that oversees technology-enabled transportation and logistics. Lefkofsky started Tempus to help his wife and because he thought that there might be a better way to battle cancer.

A decade ago, he began the Lefkofsky Family Foundation with his wife Liz. The charity is a private one, and its objective is to promote high-impact programs that are created to improve the lives of the people living in the communities it serves. Eric is also a Trustee of Lurie Children’s Hospital of Chicago. He is involved in The Museum of Science and Industry, The Art Institute of Chicago and the World Business Chicago.

A Different Direction

By forming Tempus, Eric Lefkofsky has tossed his hat into the cancer fighting ring. Not only is he using his considerable business acumen to fight the disease, but he is also battling it in a different way. When people shift direction, they often find success. One day, humankind will win the fight against cancer, and it will surprise no one if Lefkofsky is a part of that.